Results 51 to 60 of about 3,627,015 (399)

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections

open access: yesPharmaceuticals, 2023
Poor responses to medical care and the failure of pharmacological treatment for many high-frequency diseases, such as cancer and viral infections, have been widely documented.
Assunta D’Amato   +6 more
doaj   +1 more source

Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. [PDF]

open access: yes, 2007
BackgroundWe reported previously on the emergence and clinical implications of simian immunodeficiency virus (SIVmac251) mutants with a K65R mutation in reverse transcriptase (RT), and the role of CD8+ cell-mediated immune responses in suppressing ...
Bischofberger, Norbert   +10 more
core   +3 more sources

Coumarin: An emerging antiviral agent [PDF]

open access: yesHeliyon, 2020
Viral infections are responsible for many illnesses, and recent outbreaks have raised public health concerns. Despite the availability of many antiviral drugs, they are often unsuccessful due to the generation of viral mutants and less effective against their target virus.
Siddharth Manvati   +2 more
openaire   +4 more sources

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Over the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines.
Sung Won Lee   +3 more
doaj   +1 more source

Silver nanoparticles as potential antiviral agents against African swine fever virus

open access: yesMaterials Research Express, 2020
African swine fever virus (ASFV) is the cause of a highly contagious and fatal disease in domestic swine, but no vaccine or effective medicine is available so far, therefore, looking for a novel and effective anti-ASFV agent is a very imperative mission.
Tran Thi Ngoc Dung   +7 more
semanticscholar   +1 more source

Graphene‐Based Nanocomposites as Antibacterial, Antiviral and Antifungal Agents

open access: yesAdvanced Healthcare Materials, 2022
Over the past decade, there have been many interesting studies in the scientific literature about the interaction of graphene‐based polymeric nanocomposites with microorganisms to tackle antimicrobial resistance.
Seda Gungordu Er   +2 more
semanticscholar   +1 more source

Synthesis of 1,4-Disubstituted Mono and Bis-triazolocarbo-acyclonucleoside Analogues of 9-(4-Hydroxybutyl)guanine by Cu(I)-Catalyzed Click Azide-Alkyne Cycloaddition [PDF]

open access: yes, 2011
A series of novel mono-1,2,3-triazole and bis-1,2,3-triazole acyclonucleoside analogues of 9-(4-hydroxybutyl)guanine was prepared via copper(I)-catalyzed 1,3-dipolar cycloaddition of N-9 propargylpurine, N-1-propargylpyrimidines/as-triazine with the ...
Engels, Joachim W.   +2 more
core   +2 more sources

G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy [PDF]

open access: yes, 2018
G-quadruplexes (G4s) are non-canonical nucleic acids secondary structures that form within guanine-rich strands of regulatory genomic regions. G4s have been extensively described in the human genome, especially in telomeres and oncogene promoters; in ...
Richter, Sara N, Ruggiero, Emanuela
core   +1 more source

Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus [PDF]

open access: yes, 2018
Aim: The only small molecule drugs currently available for treatment of influenza A virus (IAV) are M2 ion channel blockers and sialidase inhibitors. The prototype thiazolide, nitazoxanide, has successfully completed Phase III clinical trials against ...
Andrew V Stachulski   +17 more
core   +1 more source

Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections

open access: yesPharmaceuticals, 2021
Numerous studies have led to a better understanding of the mechanisms of action of viruses in systemic infections for the development of prevention strategies and very promising antiviral therapies.
Nour Mammari   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy